September 30, 2025 · Form 4 insider transaction
Stueland Katherine sold 4,462 shares of GeneDx Holdings Corp. at $107.61 per share, a transaction worth $480.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive.